Ghent University Academic Bibliography

Journal Article
A1
open access

Transcriptional analysis reveals a markedly reduced expression of the voltage-dependent calcium channel α2δ1 subunit in canine prostate cancer compared to benign prostatic hyperplasia

Maciej Zacharski, Maciej Ugorski, Przemyslaw Prządka, Stanislaw Dzimira, Sonja Skevin (UGent) , Iwona Sidorkiewicz, Bartlomiej Liszka, Piotr Skrzypczak, Filip Van Nieuwerburgh (UGent) , Adam Krętowski, et al.

(2025) BMC VETERINARY RESEARCH. 21(1).

Add to list

Journal Article
A1
open access

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)

Linda A.J. Hendricks, Katja C.J. Verbeek, Janneke H.M. Schuurs-Hoeijmakers, Mirjam M. de Jong, Thera P. Links, Hilde Brems, Mio Aerden, Joan Brunet, Roser Lleuger-Pujol, Robert Hüneburg, et al.

(2025) GENETICS IN MEDICINE. 27(10).

Add to list

Journal Article
A1
open access

CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia

Bruno A. Cardoso, Mafalda Duque, Ana Gírio, Rita Fragoso, Mariana L. Oliveira, James R. Allen, Leila R. Martins, Nádia C. Correia, André Bortolini Silveira, Alexandra Veloso, et al.

(2024) HAEMATOLOGICA. 109(6). p.1713-1725

Add to list

Journal Article
A1
open access

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

Marc Tischkowitz, Chrystelle Colas, Sjaak Pouwels, Nicoline Hoogerbrugge, on behalf of European Reference Network GENTURI, on behalf of PHTS Guideline Dev Grp, Kathleen Claes (UGent) , Bruce Poppe (UGent) and Robin de Putter (UGent)

(2020) EUROPEAN JOURNAL OF HUMAN GENETICS. 28(10). p.1387-1393

Add to list

Journal Article
A1
open access

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

Tim Pieters (UGent) , Sara T'Sas (UGent) , Lisa Demoen (UGent) , André Pedro Pinto De Almeida, Lieven Haenebalcke (UGent) , Filip Matthijssens (UGent) , Kelly Lemeire (UGent) , Jinke D'Hont (UGent) , Frédérique Vanrockeghem (UGent) , Tino Hochepied (UGent) , et al.

(2019) SCIENTIFIC REPORTS. 9.

Add to list

Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia

Gloria Milani (UGent) , Filip Matthijssens (UGent) , Wouter Van Loocke (UGent) , Kaat Durinck (UGent) , Juliette Roels (UGent) , Sofie Peirs (UGent) , Morgan Thénoz (UGent) , Tim Pieters (UGent) , Lindy Reunes (UGent) , Béatrice Lintermans (UGent) , et al.

(2019) BRITISH JOURNAL OF HAEMATOLOGY. 185(1). p.169-174

Add to list

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

E Seront, Sylvie Rottey (UGent) , B Sautois, J Kerger, LA D'Hondt, V Verschaeve, J-L Canon, C Dopchie, JM Vandenbulcke, N Whenham, et al.

(2012) ANNALS OF ONCOLOGY. 23(10). p.2663-2670

Add to list

Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma

Mireille Van Gele (UGent) , J Helen Leonard, Nadine Van Roy (UGent) , Anthony L Cook, Anne De Paepe (UGent) and Franki Speleman (UGent)

(2001) INTERNATIONAL JOURNAL OF CANCER. 92(3). p.409-413

Academic Bibliography

Transcriptional analysis reveals a markedly reduced expression of the voltage-dependent calcium channel α2δ1 subunit in canine prostate cancer compared to benign prostatic hyperplasia

The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS)

CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia

Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia

Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers

Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma

Contents

Support

Contact